Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
90.4M
-
Shares change
-
+7.24M
-
Total reported value, excl. options
-
$1.02B
-
Value change
-
+$78.6M
-
Put/Call ratio
-
0.34
-
Number of buys
-
71
-
Number of sells
-
-49
-
Price
-
$11.25
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2018
156 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q3 2018.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.4M shares
of 334M outstanding shares and own 27.04% of the company stock.
Largest 10 shareholders include venBio Select Advisor LLC (8.66M shares), PERCEPTIVE ADVISORS LLC (7.29M shares), BlackRock Inc. (6.65M shares), ORBIMED ADVISORS LLC (5.55M shares), FRANKLIN RESOURCES INC (5.18M shares), Broadfin Capital, LLC (4.89M shares), FARALLON CAPITAL MANAGEMENT LLC (4.73M shares), Vanguard Group Inc (4.05M shares), STATE STREET CORP (3.98M shares), and GREAT POINT PARTNERS LLC (3.5M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.